CNSP
Cns Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.44
-0.40 ▼ -14.08%
🌙 3월 13일 7:52 PM ET (한국 3/14 08:52)
$2.38
-0.06 ▼ -2.63%
| Index | - | P/E | - | EPS (ttm) | -58.07 | Insider Own | - | Shs Outstand | 0.00B | Perf Week | -17.01% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | 21.25% | Insider Trans | - | Shs Float | 0.00B | Perf Month | -32.78% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | -5.37 | Inst Own | 20.03% | Short Float | 7% | Perf Quarter | -67.6% |
| Income | -0.01B | P/S | - | EPS this Y | 86.62% | Inst Trans | 0.84% | Short Ratio | 1.04 | Perf Half Y | -67.55% |
| Sales | 0.00B | P/B | 0.14 | EPS next 5Y | 50.48% | ROA | -135.6% | Short Interest | 0.04M | Perf YTD | -53.52% |
| Book/sh | 17.25 | P/C | 0.15 | EPS past 3/5Y | 90.2% 70.59% | ROE | -197.11% | 52W High | -95.58% ($55.20) | Perf Year | -92.5% |
| Cash/sh | 15.93 | P/FCF | - | Sales past 3/5Y | - | ROIC | -131.9% | 52W Low | -11.6% ($2.76) | Perf 3Y | -99.99% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 99.87% | Gross Margin | - | Volatility(W/M) | 17.71% 10.52% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.39 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.79 | EPS Q/Q | 96.2% | Profit Margin | - | RSI (14) | 25.3 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.79 | Sales Q/Q | - | SMA20 | -20.48% ($3.07) | Beta | 0.43 | Target Price | $10 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/02/25 | SMA50 | -46.72% ($4.58) | Rel Volume | 3.86 | Prev Close | $2.84 |
| Employees | 5 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -66.82% ($7.35) | Avg Volume(3M) | 0.04M | Price | $2.44 |
| IPO | 2019/11/8 | Option/Short | No/Yes | Trades | 477 | Volume | 160,990 | Change | -14.08% |
뉴스 로딩 중...